Merkel Cell Carcinoma

Showing 1 - 25 of 73

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)

Not yet recruiting
  • Merkel Cell Carcinoma
  • Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Nov 21, 2023

Merkel Cell Carcinoma Trial in Milano, Siena, Verona (Pembrolizumab, Etoposide, Cisplatin or Carboplatin)

Not yet recruiting
  • Merkel Cell Carcinoma
  • Pembrolizumab, Etoposide, Cisplatin or Carboplatin
  • Milano, Italy
  • +2 more
Oct 10, 2023

Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

Not yet recruiting
  • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 28, 2023

Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

Not yet recruiting
  • Diffuse Astrocytoma, IDH-Mutant
  • +20 more
  • NEO212 Oral Capsule
  • +8 more
  • (no location specified)
Sep 18, 2023

Merkel Cell Carcinoma Clinical Trial Engagement Patterns

Not yet recruiting
  • Merkel Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Sep 8, 2023

    Sarcoma, Merkel Cell Carcinoma Trial in United States (CRD3874)

    Recruiting
    • Sarcoma
    • Merkel Cell Carcinoma
    • Basking Ridge, New Jersey
    • +6 more
    Aug 28, 2023

    Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Orlando (Exercise Test)

    Not yet recruiting
    • Cutaneous Melanoma
    • +2 more
    • Exercise Test
    • Orlando, Florida
      AdventHealth Translational Research Institute
    Aug 18, 2023

    Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +18 more
    • Basking Ridge, New Jersey
    • +6 more
    May 18, 2023

    Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

    Recruiting
    • Adenoid Cystic Skin Carcinoma
    • +38 more
    • Biopsy
    • +6 more
    • Los Angeles, California
    • +35 more
    Jan 31, 2023

    Advanced Solid Tumors, Lymphoma, Gastric Cancer Trial in United States (FT500, Nivolumab, Pembrolizumab)

    Completed
    • Advanced Solid Tumors
    • +17 more
    • San Diego, California
    • +3 more
    Jan 27, 2023

    Merkel Cell Carcinoma Trial in Milan (Retifanlimab, Cisplatin, Etoposide)

    Recruiting
    • Merkel Cell Carcinoma
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
    Jan 4, 2023

    Merkel Cell Carcinoma, Neuroendocrine Carcinoma of the Skin, Trabecular Carcinoma of the Skin Trial in Tampa (Lenvatinib Oral

    Recruiting
    • Merkel Cell Carcinoma
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 30, 2022

    Hepatocellular Carcinoma, Squamous Cell Carcinoma of the Lung, Merkel Cell Carcinoma Trial in Houston, Milwaukee (CAR-GPC3 T

    Recruiting
    • Hepatocellular Carcinoma
    • +3 more
    • CAR-GPC3 T Cells
    • Dallas, Texas
    • +2 more
    Dec 20, 2022

    Malignant Melanoma, Merkel Cell Carcinoma Trial in Bern (Visionsenseā„¢ VS3 - Stereoscopic High Definition Visualisation System

    Completed
    • Malignant Melanoma
    • Merkel Cell Carcinoma
    • Visionsenseā„¢ VS3 - Stereoscopic High Definition Visualisation System (VS3-3DHD)
    • Bern, Kanton Bern, Switzerland
      Inselspital, University Hospital Bern, University of Bern
    Dec 7, 2022

    Advanced Solid Tumor, MSI-H/dMMR Tumors, Cutaneous Squamous Cell Carcinoma Trial in Worldwide (INCB099280)

    Recruiting
    • Advanced Solid Tumor
    • +11 more
    • Boston, Massachusetts
    • +30 more
    Dec 1, 2022

    Merkel Cell Carcinoma Trial in Worldwide (Pembrolizumab (MK-3475))

    Active, not recruiting
    • Merkel Cell Carcinoma
    • Pembrolizumab (MK-3475)
    • New York, New York
    • +21 more
    Nov 30, 2022

    Merkel Cell Carcinoma Trial in Australia (Carboplatin, Etoposide, Radiotherapy)

    Completed
    • Merkel Cell Carcinoma
    • Campbelltown, New South Wales, Australia
    • +12 more
    Nov 17, 2022

    Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))

    Active, not recruiting
    • Merkel Cell Carcinoma
    • Skin Cancer
    • Tampa, Florida
    • +1 more
    Nov 11, 2022

    DOTATOC PET/CT for Imaging NET Patients

    Recruiting
    • Neuroendocrine Tumors
    • +15 more
    • 68Ga-DOTATOC PET/CT
    • 18F-FDG PET/CT
    • Vancouver, British Columbia, Canada
      BC Cancer
    Nov 2, 2022

    Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

    Recruiting
    • Advanced Solid Tumor
    • +24 more
    • MDNA11 Monotherapy
    • MDNA11 in combination with checkpoint inhibitor
    • Santa Monica, California
    • +7 more
    Nov 1, 2022

    Merkel Cell Carcinoma Trial (Pembrolizumab, Lutetium Lu 177 dotatate)

    Not yet recruiting
    • Merkel Cell Carcinoma
    • (no location specified)
    Oct 12, 2022

    Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Tampa (Excerise, Checkpoint Blockade,

    Recruiting
    • Cutaneous Melanoma
    • +2 more
    • Excerise
    • Checkpoint Blockade, Immune
    • Tampa, Florida
      Moffitt Cancer Center
    Sep 21, 2022

    Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II Trial in Australia (Avelumab, Placebo)

    Recruiting
    • Merkel Cell Carcinoma
    • +5 more
    • Port Macquarie, New South Wales, Australia
    • +17 more
    Aug 30, 2022

    Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

    Recruiting
    • Melanoma
    • +14 more
    • LITT + Pembrolizumab
    • Gainesville, Florida
    • +1 more
    Aug 22, 2022

    Merkel Cell Carcinoma Trial in Philadelphia (Pembrolizumab)

    Not yet recruiting
    • Merkel Cell Carcinoma
    • Philadelphia, Pennsylvania
      Penn Medicine
    Aug 9, 2022